New patent expiration for Mayne Pharma drug DORYX MPC

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for DORYX+MPC
Annual Drug Patent Expirations for DORYX+MPC

Doryx Mpc is a drug marketed by Mayne Pharma and is included in one NDA. It is available from two suppliers. There are five patents protecting this drug and one Paragraph IV challenge.

Drug patent litigation for DORYX MPC.

This drug has two patent family members in two countries.

The generic ingredient in DORYX MPC is doxycycline hyclate. Two suppliers are listed for this compound. Additional details are available on the doxycycline hyclate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions
Scroll to Top